Alaunos Therapeutics Stock Widgets and Gadgets
| TCRT Stock | USD 2.72 0.04 1.49% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- TCRT Alaunos Therapeutics
- Latest What risks investors should watch in Alaunos Therapeutics Inc. stock - Market Trend Report Consistent Income Trade Ideas - newser.com
- TCRT 2.72 0.04
- Low 2.65
- High 2.82
- Alpha 0.0285
- Beta 0.99
- Return On Equity -1.07
- Return On Asset -0.54
- Operating Margin (672.83) %
- Current Valuation (260.97 K)
- Shares Outstanding 2.21 M
- Shares Owned By Insiders 3.78 %
- Shares Owned By Institutions 4.76 %
- Number Of Shares Shorted 108.94 K
- Price To Book 1.58 X
- Price To Sales 1,053 X
- Revenue 10 K
- Gross Profit (581 K)
- EBITDA (4.68 M)
- Net Income (4.68 M)
- Cash And Equivalents 60.01 M
- Cash Per Share 0.28 X
- Total Debt 692 K
- Debt To Equity 0.69 %
- Current Ratio 2.29 X
- Book Value Per Share 1.76 X
- Cash Flow From Operations (4.97 M)
- Short Ratio 0.10 X
- Earnings Per Share (2.47) X
- Target Price 1.75
- Beta -0.85
- Market Capitalization 6.32 M
- Total Asset 2.75 M
- Retained Earnings (920.45 M)
- Working Capital 2.06 M
- Net Asset 2.75 M
- Accumulation Distribution 0.0603
- Daily Balance Of Power 0.2353
- Rate Of Daily Change 1.01
- Day Median Price 2.74
- Day Typical Price 2.73
- Market Facilitation Index 0.17
- Price Action Indicator 0.005
- Period Momentum Indicator 0.04
- Relative Strength Index 58.63
Market Snapshot Widget Example
DAX Index Germany | 23,958 0.67 | |
Taiwan Weighted Taiwan | 28,233 0.19 | |
PSI 20 Stock Portugal | 8,427 0.23 | |
CROBEX Croatia | 3,815 0.21 | |
Budapest SE Hungary | 107,320 0.31 | |
IDX 30 Jakarta Indonesia | 436.96 0.84 | |
ISEQ 20 Price Ireland | 1,980 0 | |
NYSE Comp USA | 21,460 0.04 | |
Tel Aviv 35 Israel | 3,273 0.41 | |
Coreshares Index Tracker South Afric | 1,344 0.22 | |
IPC MEXICO Mexico | 62,769 0.19 | |
Bursa Malaysia Construction Malaysia | 311.80 0.95 | |
IBEX 35 Index Spain | 16,033 0.05 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 4,808 1.27 | |
SPASX Dividend Opportunities Australia | 1,888 0.27 | |
VN Index Vietnam | 1,640 1.79 | |
Bucharest BET-NG Romania | 1,694 0.19 | |
AMS Small Cap Netherlands | 1,534 0.05 | |
Oslo Exchange Mutual Norway | 1,588 0.31 | |
BEL Small Belgium | 8,583 0.45 | |
Basic Materials Brazil | 5,688 1.20 | |
Swiss Leader Price Switzerland | 2,011 0.49 | |
Fondo Mutuo ETF Chile | 1,809 1.59 | |
Athens General Comp Greece | 1,995 0.5 | |
Stock Exchange Of Thailand | 1,310 0.39 | |
PX Prague Stock Czech Repub | 2,397 0.88 | |
THE PHILIPPINE STOCK Philippines | 5,930 0.57 | |
WIG 30 Poland | 3,860 1.32 |
Investing Ideas
In addition to having Alaunos Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Alaunos Therapeutics
Compare Alaunos Therapeutics To Peers
Additional Tools for Alaunos Stock Analysis
When running Alaunos Therapeutics' price analysis, check to measure Alaunos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alaunos Therapeutics is operating at the current time. Most of Alaunos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alaunos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alaunos Therapeutics' price. Additionally, you may evaluate how the addition of Alaunos Therapeutics to your portfolios can decrease your overall portfolio volatility.